Thomas Wilton
Profile
Thomas Wilton served as the Chief Business Officer at LogicBio Therapeutics, Inc. He graduated from Brunel University and the University of Leeds with graduate degrees, and from the University of London with an undergraduate degree.
Former positions of Thomas Wilton
| Companies | Position | End |
|---|---|---|
| LOGICBIO THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Training of Thomas Wilton
| University of London | Undergraduate Degree |
| University of Leeds | Graduate Degree |
| Brunel University | Graduate Degree |
Experiences
Positions held
Linked companies
| Private companies | 1 |
|---|---|
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology LogicBio Therapeutics, Inc. engages in the development of a genome editing technology platform. It focuses on the commercialization of GeneRide, which enables the site-specific integration of a therapeutic transgene without nucleases or exogenous promoters by harnessing the native process of homologous recombination. Its pipeline includes LB-001, LB-301 and LB-401. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Lexington, MA. | Health Technology |
- Stock Market
- Insiders
- Thomas Wilton